[HTML][HTML] Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial
EJ Lenze, C Mattar, CF Zorumski, A Stevens… - Jama, 2020 - jamanetwork.com
Importance Coronavirus disease 2019 (COVID-19) may lead to serious illness as a result of
an excessive immune response. Fluvoxamine may prevent clinical deterioration by …
an excessive immune response. Fluvoxamine may prevent clinical deterioration by …
[PDF][PDF] Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial
EJ Lenze, C Mattar, CF Zorumski… - …, 2020 - regenhealthsolutions.info
OBJECTIVE To determine whether fluvoxamine, given during mild COVID-19 illness,
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial.
EJ Lenze, C Mattar, CF Zorumski, A Stevens… - JAMA, 2020 - europepmc.org
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19:
A Randomized Clinical Trial. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
A Randomized Clinical Trial. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …
[PDF][PDF] Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial
EJ Lenze, C Mattar, CF Zorumski, A Stevens… - …, 2020 - researchgate.net
OBJECTIVE To determine whether fluvoxamine, given during mild COVID-19 illness,
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
[PDF][PDF] Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial
EJ Lenze, C Mattar, CF Zorumski, A Stevens… - …, 2020 - amedeolucente.it
OBJECTIVE To determine whether fluvoxamine, given during mild COVID-19 illness,
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial.
EJ Lenze, C Mattar, CF Zorumski… - JAMA: Journal of …, 2020 - search.ebscohost.com
Abstract < bold> Importance: </bold> Coronavirus disease 2019 (COVID-19) may
lead to serious illness as a result of an excessive immune response. Fluvoxamine may …
lead to serious illness as a result of an excessive immune response. Fluvoxamine may …
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients with Symptomatic COVID-19: A Randomized Clinical Trial
EJ Lenze, C Mattar, CF Zorumski… - JAMA-Journal of the …, 2020 - profiles.wustl.edu
Abstract Importance: Coronavirus disease 2019 (COVID-19) may lead to serious illness as a
result of an excessive immune response. Fluvoxamine may prevent clinical deterioration by …
result of an excessive immune response. Fluvoxamine may prevent clinical deterioration by …
[PDF][PDF] Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial
EJ Lenze, C Mattar, CF Zorumski, A Stevens… - …, 2020 - webpoisoncontrol.org
OBJECTIVE To determine whether fluvoxamine, given during mild COVID-19 illness,
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial
EJ Lenze, C Mattar, CF Zorumski, A Stevens… - JAMA, 2020 - jamanetwork.com
Importance Coronavirus disease 2019 (COVID-19) may lead to serious illness as a result of
an excessive immune response. Fluvoxamine may prevent clinical deterioration by …
an excessive immune response. Fluvoxamine may prevent clinical deterioration by …
[PDF][PDF] Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial
EJ Lenze, C Mattar, CF Zorumski, A Stevens… - …, 2020 - academia.edu
OBJECTIVE To determine whether fluvoxamine, given during mild COVID-19 illness,
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …
prevents clinical deterioration and decreases the severity of disease. DESIGN, SETTING …